Response to Maojo and Kulikowski.
Author(s): Friedman, Charles P
DOI: 10.1136/amiajnl-2013-002120
Author(s): Friedman, Charles P
DOI: 10.1136/amiajnl-2013-002120
To describe a collaborative approach for developing an electronic health record (EHR) phenotyping algorithm for drug-induced liver injury (DILI).
Author(s): Overby, Casey Lynnette, Pathak, Jyotishman, Gottesman, Omri, Haerian, Krystl, Perotte, Adler, Murphy, Sean, Bruce, Kevin, Johnson, Stephanie, Talwalkar, Jayant, Shen, Yufeng, Ellis, Steve, Kullo, Iftikhar, Chute, Christopher, Friedman, Carol, Bottinger, Erwin, Hripcsak, George, Weng, Chunhua
DOI: 10.1136/amiajnl-2013-001930
Generalizable, high-throughput phenotyping methods based on supervised machine learning (ML) algorithms could significantly accelerate the use of electronic health records data for clinical and translational research. However, they often require large numbers of annotated samples, which are costly and time-consuming to review. We investigated the use of active learning (AL) in ML-based phenotyping algorithms.
Author(s): Chen, Yukun, Carroll, Robert J, Hinz, Eugenia R McPeek, Shah, Anushi, Eyler, Anne E, Denny, Joshua C, Xu, Hua
DOI: 10.1136/amiajnl-2013-001945
To develop algorithms to improve efficiency of patient phenotyping using natural language processing (NLP) on text data. Of a large number of note titles available in our database, we sought to determine those with highest yield and precision for psychosocial concepts.
Author(s): Gundlapalli, Adi V, Redd, Andrew, Carter, Marjorie, Divita, Guy, Shen, Shuying, Palmer, Miland, Samore, Matthew H
DOI: 10.1136/amiajnl-2013-001946
We define and validate an architecture for systems that identify patient cohorts for clinical trials from multiple heterogeneous data sources. This architecture has an explicit query model capable of supporting temporal reasoning and expressing eligibility criteria independently of the representation of the data used to evaluate them.
Author(s): Bache, Richard, Miles, Simon, Taweel, Adel
DOI: 10.1136/amiajnl-2013-001858
To study the relation between electronic health record (EHR) variables and healthcare process events.
Author(s): Hripcsak, George, Albers, David J
DOI: 10.1136/amiajnl-2013-001922
Widespread sharing of data from electronic health records and patient-reported outcomes can strengthen the national capacity for conducting cost-effective clinical trials and allow research to be embedded within routine care delivery. While pragmatic clinical trials (PCTs) have been performed for decades, they now can draw on rich sources of clinical and operational data that are continuously fed back to inform research and practice. The Health Care Systems Collaboratory program, initiated [...]
Author(s): Richesson, Rachel L, Hammond, W Ed, Nahm, Meredith, Wixted, Douglas, Simon, Gregory E, Robinson, Jennifer G, Bauck, Alan E, Cifelli, Denise, Smerek, Michelle M, Dickerson, John, Laws, Reesa L, Madigan, Rosemary A, Rusincovitch, Shelley A, Kluchar, Cynthia, Califf, Robert M
DOI: 10.1136/amiajnl-2013-001926
Celiac disease (CD) is a lifelong immune-mediated disease with excess mortality. Early diagnosis is important to minimize disease symptoms, complications, and consumption of healthcare resources. Most patients remain undiagnosed. We developed two electronic medical record (EMR)-based algorithms to identify patients at high risk of CD and in need of CD screening.
Author(s): Ludvigsson, Jonas F, Pathak, Jyotishman, Murphy, Sean, Durski, Matthew, Kirsch, Phillip S, Chute, Christophe G, Ryu, Euijung, Murray, Joseph A
DOI: 10.1136/amiajnl-2013-001924
The clinical course of multiple sclerosis (MS) is highly variable, and research data collection is costly and time consuming. We evaluated natural language processing techniques applied to electronic medical records (EMR) to identify MS patients and the key clinical traits of their disease course.
Author(s): Davis, Mary F, Sriram, Subramaniam, Bush, William S, Denny, Joshua C, Haines, Jonathan L
DOI: 10.1136/amiajnl-2013-001999
Large-scale biorepositories that couple biologic specimens with electronic health records containing documentation of phenotypic expression can accelerate scientific research and discovery. However, differences between those subjects who participate in biorepository-based research and the population from which they are drawn may influence research validity. While an opt-out approach to biorepository-based research enhances inclusiveness, empirical research evaluating voluntariness, risk, and the feasibility of an opt-out approach is sparse, and factors influencing patients' [...]
Author(s): Rosenbloom, S Trent, Madison, Jennifer L, Brothers, Kyle B, Bowton, Erica A, Clayton, Ellen Wright, Malin, Bradley A, Roden, Dan M, Pulley, Jill
DOI: 10.1136/amiajnl-2013-001937